<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>bidding &#8211; Canyon Crest Guide Local News</title>
	<atom:link href="https://canyoncrestguide.com/tag/bidding/feed/" rel="self" type="application/rss+xml" />
	<link>https://canyoncrestguide.com</link>
	<description>Canyon Crest News</description>
	<lastBuildDate>Tue, 17 Feb 2026 13:50:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://canyoncrestguide.com/wp-content/uploads/2023/08/Canyon-Crest-Guide-Local-News-100x100-1-65x65.jpeg</url>
	<title>bidding &#8211; Canyon Crest Guide Local News</title>
	<link>https://canyoncrestguide.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Warner Bros. reopens bidding process, allowing Paramount to make its case</title>
		<link>https://canyoncrestguide.com/warner-bros-reopens-bidding-process-allowing-paramount-to-make-its-case/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Tue, 17 Feb 2026 13:50:03 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[allowing]]></category>
		<category><![CDATA[bidding]]></category>
		<category><![CDATA[board]]></category>
		<category><![CDATA[Bros]]></category>
		<category><![CDATA[case]]></category>
		<category><![CDATA[company]]></category>
		<category><![CDATA[netflix]]></category>
		<category><![CDATA[netflix deal]]></category>
		<category><![CDATA[Offer]]></category>
		<category><![CDATA[paramount]]></category>
		<category><![CDATA[Process]]></category>
		<category><![CDATA[proposal]]></category>
		<category><![CDATA[psky]]></category>
		<category><![CDATA[reopens]]></category>
		<category><![CDATA[shareholder]]></category>
		<category><![CDATA[stockholder]]></category>
		<category><![CDATA[tuesday statement]]></category>
		<category><![CDATA[Warner]]></category>
		<category><![CDATA[warner bros.]]></category>
		<category><![CDATA[warner last week]]></category>
		<category><![CDATA[wbd]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/warner-bros-reopens-bidding-process-allowing-paramount-to-make-its-case/</guid>

					<description><![CDATA[[ad_1] Warner Bros. Discovery is cracking open the door to allow spurned bidder, Paramount Skydance, to make its case — but Warner’s board still maintains its preference for Netflix’s competing proposal. Warner’s move to reopen talks comes after weeks of pressure from Paramount, which submitted an enhanced offer to buy Warner last week. Paramount’s willingness [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk</title>
		<link>https://canyoncrestguide.com/pfizer-clinches-deal-for-obesity-drug-developer-metsea-after-a-bidding-war-with-novo-nordisk/</link>
		
		<dc:creator><![CDATA[Tony Ramos]]></dc:creator>
		<pubDate>Sun, 09 Nov 2025 14:32:07 +0000</pubDate>
				<category><![CDATA[Daily News]]></category>
		<category><![CDATA[127337193]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[bidding]]></category>
		<category><![CDATA[business]]></category>
		<category><![CDATA[clinches]]></category>
		<category><![CDATA[deal]]></category>
		<category><![CDATA[developer]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[General news]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Mergers and acquisitions]]></category>
		<category><![CDATA[Metsea]]></category>
		<category><![CDATA[Nordisk]]></category>
		<category><![CDATA[Novo]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[pfizer]]></category>
		<category><![CDATA[U.S. news]]></category>
		<category><![CDATA[war]]></category>
		<guid isPermaLink="false">https://canyoncrestguide.com/pfizer-clinches-deal-for-obesity-drug-developer-metsea-after-a-bidding-war-with-novo-nordisk/</guid>

					<description><![CDATA[[ad_1] Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk NEW YORK &#8212; U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
